YahooSeptember 13, 2026 at 10:50 AM NYLast Month
3 Small-Cap Biotechs With Binary Catalysts on the Calendar
Kodiak Sciences, Capricor Therapeutics and Invivyd each face pivotal clinical trial or FDA decisions before the end of 2026 that could significantly move their stock prices.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
